Establishment Labs (NASDAQ:ESTA) Trading Up 5.4% - What's Next?

Establishment Labs Holdings Inc. (NASDAQ:ESTA - Get Free Report) shares traded up 5.4% on Wednesday . The company traded as high as $29.51 and last traded at $28.78. 96,890 shares traded hands during mid-day trading, a decline of 78% from the average session volume of 434,704 shares. The stock had previously closed at $27.31.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on ESTA. Stephens reissued an "overweight" rating and set a $52.00 target price on shares of Establishment Labs in a research note on Thursday, March 6th. Needham & Company LLC began coverage on Establishment Labs in a research report on Monday. They set a "hold" rating on the stock. Two analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $57.40.

Establishment Labs Trading Up 3.2 %

The company has a quick ratio of 2.29, a current ratio of 3.62 and a debt-to-equity ratio of 5.94. The company's 50-day moving average price is $36.44 and its 200-day moving average price is $40.10. The firm has a market cap of $903.46 million, a price-to-earnings ratio of -12.14 and a beta of 0.77.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last posted its quarterly earnings data on Wednesday, February 26th. The company reported ($0.98) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.64) by ($0.34). The firm had revenue of $44.51 million during the quarter, compared to analyst estimates of $44.45 million. Establishment Labs had a negative return on equity of 184.55% and a negative net margin of 46.13%. Equities analysts expect that Establishment Labs Holdings Inc. will post -2.41 EPS for the current fiscal year.

Institutional Investors Weigh In On Establishment Labs

Several institutional investors and hedge funds have recently added to or reduced their stakes in ESTA. Quarry LP purchased a new position in shares of Establishment Labs in the fourth quarter worth about $27,000. R Squared Ltd purchased a new position in Establishment Labs in the 4th quarter worth approximately $36,000. KLP Kapitalforvaltning AS acquired a new position in shares of Establishment Labs during the 4th quarter worth approximately $161,000. Patriot Financial Group Insurance Agency LLC purchased a new stake in shares of Establishment Labs in the first quarter valued at approximately $234,000. Finally, Hood River Capital Management LLC increased its holdings in shares of Establishment Labs by 236.4% in the fourth quarter. Hood River Capital Management LLC now owns 5,920 shares of the company's stock valued at $273,000 after purchasing an additional 4,160 shares during the last quarter. Institutional investors and hedge funds own 72.91% of the company's stock.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.